Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease

The validated results reflect the landscape of biological changes accompanying type 1 diabetes. For example, the association of the targeted apolipoproteins with fasting C-peptide/glucose ratios in the first year after diagnosis is likely to relate to lipid abnormalities observed in individuals with type 1 diabetes, and reiterates the connection of apolipoproteins with the underlying changes accompanying the disease. Further research is needed to explore the clinical value and relevance of these targets.

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2025-02-28
DOI
https://doi.org/10.1007/s00125-025-06394-7
Citations
2
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
3.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease

Mikael Knip, Søren Brunak, Lut Overbergh, Riitta Lahesmaa et al.
2 citations
Diabetologia
Diabetes and associated disorders
3.63
article

Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease

Mikael Knip, Søren Brunak, Lut Overbergh, Riitta Lahesmaa, Tommi Välikangas, Chantal Mathieu, Laura L. Elo, M. Karoliina Hirvonen, Mark Peakman, Robert Moulder, Tomi Suomi
article en
2 citations

Abstract

The validated results reflect the landscape of biological changes accompanying type 1 diabetes. For example, the association of the targeted apolipoproteins with fasting C-peptide/glucose ratios in the first year after diagnosis is likely to relate to lipid abnormalities observed in individuals with type 1 diabetes, and reiterates the connection of apolipoproteins with the underlying changes accompanying the disease. Further research is needed to explore the clinical value and relevance of these targets.

DiabetologiaVol. 68(6)
University of Copenhagen (DK), Åbo Akademi University (FI), University of Helsinki (FI), University of Turku (FI), Turku Centre for Computer Science (FI), Universitair Ziekenhuis Leuven (BE), Helsinki University Hospital (FI), Novo Nordisk Foundation (DK), Turku PET Centre (FI), Tampere University Hospital (FI), Tampere University (FI), Sanofi (United Kingdom) (GB), KU Leuven (BE)
Juvenile Diabetes Research Foundation International, Leona M. and Harry B. Helmsley Charitable Trust, Yrjö Jahnssonin Säätiö, European Federation of Pharmaceutical Industries and Associations, Academy of Finland, Jane ja Aatos Erkon Säätiö, Päivikki ja Sakari Sohlbergin Säätiö, Turun Yliopisto, Sigrid Juséliuksen Säätiö, Biocenter Finland, Business Finland, European Research Council, Turun yliopiston tutkijakoulu, H2020 Health
Good health and well-being
Openalex Percentile: Top 9%
Diabetes and associated disorders
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.